Literature DB >> 19906118

Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium.

P Boknik1, S Grote-Wessels, G Barteska, M Jiang, F U Müller, W Schmitz, J Neumann, L Birnbaumer.   

Abstract

BACKGROUND AND
PURPOSE: Classically, stimulation of muscarinic cholinoceptors exerts negative inotropic and chronotropic effects in the atrium of mammalian hearts. These effects are crucial to the vagal regulation of the heart beat. This effect is assumed to be mediated via GTP binding (G) proteins, because they can be abolished by Pertussis toxin. However, it is unknown which G proteins are involved. EXPERIMENTAL APPROACH: We studied contractility in isolated left or right atrium from genetically manipulated mice with deletion of one of two G proteins, either of the alpha subunit of G(i2) protein (G(i2)alpha) or of the alpha subunit of G(o) protein (G(o)alpha). Preparations were stimulated with carbachol alone or after pretreatment with the beta-adrenoceptor agonist isoprenaline. For comparison, the effects of carbachol on L-type Ca(2+)-channels in isolated ventricular cardiomyocytes were studied. KEY
RESULTS: The negative inotropic and chronotropic effects of carbachol alone or in the presence of isoprenaline were identical in atria from knockout or wild-type mice. However, the effect of carbachol on isoprenaline-activated L-type Ca(2+)-channel in isolated ventricular cardiomyocytes was greatly attenuated in both types of knockout mice studied. CONCLUSIONS AND IMPLICATIONS: These data imply that there is either redundancy of G proteins for signal transduction or that Pertussis toxin-sensitive proteins other than G(i2)alpha and G(o)alpha mediate the vagal stimulation in the atrium. Moreover, different G proteins mediate the effect of carbachol in ventricle compared with atrium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906118      PMCID: PMC2795222          DOI: 10.1111/j.1476-5381.2009.00441.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

Review 1.  Adrenergic and muscarinic receptors in the human heart.

Authors:  O E Brodde; M C Michel
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  Targeted inactivation of alphai2 or alphai3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells.

Authors:  M O Sowell; C Ye; D A Ricupero; S Hansen; S J Quinn; P M Vassilev; R M Mortensen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin.

Authors:  M Böhm; R Brückner; J Neumann; W Schmitz; H Scholz; J Starbatty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

4.  Two types of calcium channels in guinea pig ventricular myocytes.

Authors:  R Mitra; M Morad
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro.

Authors:  P W Stengel; J Gomeza; J Wess; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

6.  Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes.

Authors:  K Nagata; C Ye; M Jain; D S Milstone; R Liao; R M Mortensen
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

7.  Functional studies in atrium overexpressing A1-adenosine receptors.

Authors:  J Neumann; U Vahlensieck; P Boknik; B Linck; H Lüss; F U Müller; G P Matherne; W Schmitz
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

8.  Muscarinic inhibitory and stimulatory regulation of the L-type Ca2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase.

Authors:  A E Belevych; R D Harvey
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

9.  Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors.

Authors:  John T Fisher; Sandra G Vincent; Jesus Gomeza; Masahisa Yamada; Jürgen Wess
Journal:  FASEB J       Date:  2004-02-20       Impact factor: 5.191

10.  Muscarinic cholinergic inhibition of beta-adrenergic stimulation of phospholamban phosphorylation and Ca2+ transport in guinea pig ventricles.

Authors:  J P Lindemann; A M Watanabe
Journal:  J Biol Chem       Date:  1985-10-25       Impact factor: 5.157

View more
  9 in total

1.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

2.  Augmented glucose-induced insulin release in mice lacking G(o2), but not G(o1) or G(i) proteins.

Authors:  Ying Wang; Sangeun Park; Neil S Bajpayee; Yoshiko Nagaoka; Guylain Boulay; Lutz Birnbaumer; Meisheng Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 3.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

4.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

5.  Targeted nonviral gene-based inhibition of Gα(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation.

Authors:  Gary L Aistrup; Ivan Cokic; Jason Ng; David Gordon; Hemanth Koduri; Suzanne Browne; Dorina Arapi; Yogita Segon; Jacob Goldstein; Abigail Angulo; J Andrew Wasserstrom; Jeffrey J Goldberger; Alan H Kadish; Rishi Arora
Journal:  Heart Rhythm       Date:  2011-08-25       Impact factor: 6.343

Review 6.  Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system.

Authors:  Rishi Arora
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-08-01

Review 7.  Local innervation and atrial fibrillation.

Authors:  S Rasika Wickramasinghe; Vickas V Patel
Journal:  Circulation       Date:  2013-10-01       Impact factor: 29.690

8.  Phenotyping of Mice with Heart Specific Overexpression of A2A-Adenosine Receptors: Evidence for Cardioprotective Effects of A2A-Adenosine Receptors.

Authors:  Peter Boknik; Katharina Drzewiecki; John Eskandar; Ulrich Gergs; Stephanie Grote-Wessels; Larissa Fabritz; Paulus Kirchhof; Frank U Müller; Frank Stümpel; Wilhelm Schmitz; Norbert Zimmermann; Uwe Kirchhefer; Joachim Neumann
Journal:  Front Pharmacol       Date:  2018-01-22       Impact factor: 5.810

9.  Deletion of the α subunit of the heterotrimeric Go protein impairs cerebellar cortical development in mice.

Authors:  Hye Lim Cha; Jung-Mi Choi; Huy-Hyen Oh; Narayan Bashyal; Sung-Soo Kim; Lutz Birnbaumer; Haeyoung Suh-Kim
Journal:  Mol Brain       Date:  2019-06-20       Impact factor: 4.041

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.